Skip to main content Skip to navigation
Recombinant Human TNF

BD Pharmingen™ Recombinant Human TNF

Product Details
Down Arrow Up Arrow


Tumor Necrosis Factor (TNF, also known as TNF-α) is a potent lymphoid factor which exerts cytotoxic effects on a wide range of tumor cells and certain other target cells. Human TNF is a 17.5 kD protein containing 157 amino acid residues.  Recombinant human TNF (Cat. No. 554618) is supplied as a frozen liquid comprised of 0.22 μm sterile-filtered aqueous buffered solution containing bovine serum albumin, with no preservatives.  Recombinant human TNF is ≥ 95% pure as determined by SDS-PAGE, and an absorbance assay based on the Beers-Lambert law.  The endotoxin level is ≤ 0.1 ng/μg of human TNF, as measured in a chromogenic LAL assay.

Preparation And Storage

Store product at -80°C prior to use or for long term storage of stock solutions. Rapidly thaw and quick-spin product prior to use. Avoid multiple freeze-thaws of product. This preparation contains no preservatives, thus it should be handled under aseptic conditions.

Recommended Assay Procedures

Upon initial thawing, recombinant human TNF (Cat. No. 554618) should be aliquoted into polypropylene microtubes and frozen at -80°C for future use. Alternatively, the product can be diluted in sterile neutral buffer containing not less than 0.5-10 mg/mL carrier protein, such as human or bovine albumin, aliquoted and stored at -80°C.  For in vitro biological assay use, carrier-protein concentrations of  ≥ 1 mg/mL are recommended.  For use as an ELISA standard, carrier-protein concentrations of 5-10 mg/mL are recommended.  Failure to add carrier protein or store at indicated temperatures may result in a loss of activity.  Carrier proteins should be pre-screened for possible effects in each investigator's experimental system.  Carrier proteins may have an undesired influence on experimental results due to toxicity, high endotoxin levels or possible blocking activity.

ELISA Standard:  Recombinant human TNF (Cat. No. 554618) can be useful as a quantitative standard for measuring human TNF protein levels using sandwich ELISA with the purified MAb1 antibody (Cat. No. 551220) as a capture antibody and biotinylated MAb11 antibody (Cat. No. 554511) as the detection antibody. To obtain linear standard curves, investigators may want to consider using doubling dilutions of  recombinant human TNF standard from 2000-15 pg/mL to be included in each ELISA plate.  For measuring human TNF in serum or plasma, investigators are highly encouraged to use BD OptEIA™ Human TNF ELISA Set (Cat. No. 555212) or BD OptEIA™ Human TNF ELISA Kit II (Cat. No. 550610).

Bioassay:  Investigators are advised that the Bioassay application is not routinely tested for this material and are highly encouraged to both titrate this material and include appropriate controls in relevant experiments. An  activity range of 0.05 - 2.0 x 10^9 units/mg, encompassing an

ED50= 5-200 pg/mL, has previously been reported using L929 as indicator cells in a cytolysis assay, with a unit defined as the amount of material needed to stimulate a half-maximal response at cytokine saturation.

Product Notices

  1. Since applications vary, each investigator should titrate the reagent to obtain optimal results.
  2. Source of all serum proteins is from USDA inspected abattoirs located in the United States.
  3. Please refer to for technical protocols.
554618 Rev. 2
Citations & References
Down Arrow Up Arrow

Development References (4)

  1. Hogan MM, Vogel SN. Production of tumor necrosis factor by rIFN-gamma-primed C3H/HeJ (Lpsd) macrophages requires the presence of lipid A-associated proteins. J Immunol. 1988; 141(12):4196-4202. (Biology). View Reference
  2. Jaattela, M. . Biologic activities and mechanisms of action of tumor necrosis factor-α/cachectin. Lab Invest. 1991; 64:724-742. (Biology).
  3. Prussin C, Metcalfe DD. Detection of intracytoplasmic cytokine using flow cytometry and directly conjugated anti-cytokine antibodies. J Immunol Methods. 1995; 188(1):117-128. (Biology). View Reference
  4. Wang AM, Creasey AA, Ladner MB, et al. Molecular cloning of the complementary DNA for human tumor necrosis factor. Science. 1985; 228(4696):149-154. (Biology). View Reference
View All (4) View Less
554618 Rev. 2

Please refer to Support Documents for Quality Certificates

Global - Refer to manufacturer's instructions for use and related User Manuals and Technical data sheets before using this products as described

Comparisons, where applicable, are made against older BD Technology, manual methods or are general performance claims.  Comparisons are not made against non-BD technologies, unless otherwise noted.

For Research Use Only. Not for use in diagnostic or therapeutic procedures.